Squamous Cell Carcinoma of the Larynx Clinical Trials

10 clinical trials for Squamous Cell Carcinoma of the Larynx across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer — RECRUITING · PHASE1
• De-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck — RECRUITING · PHASE2
• Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome — RECRUITING
• European Larynx Organ Preservation Study (ELOS) [MK-3475-C44] — RECRUITING · PHASE2
• Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma — COMPLETED · PHASE1
• Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC — WITHDRAWN · PHASE2
• Fluorescence-guided Surgery in Laryngeal- and Hypopharyngeal Cancer: a Feasibility Trial — NOT_YET_RECRUITING · PHASE2
• Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC) — WITHDRAWN · PHASE2
• HYpofractionateD RadioAblative (HYDRA) Treatment of Advanced Laryngeal Cancer — TERMINATED · PHASE1

Refine this search